Peptide Skincare & BeautySkin science and ingredient guides

Ingredient or product comparison

GHK-Cu Support Anti-Aging Stack: Head-to-Head Comparison

GHK-Cu Copper-binding tripeptide activating collagen genes (COL1A1, COL3A1) + antioxidant enzyme upregulation Dermal thickening, wound healing, reduction of photoaging markers N/A (baseline compound) Daily (topical) or 2–3×/week (injectable) Essential structur

This source-based comparison does not add ratings or recommend a winner.

  • GHK-Cu
  • Copper-binding tripeptide activating collagen genes (COL1A1, COL3A1) + antioxidant enzyme upregulation
  • Dermal thickening, wound healing, reduction of photoaging markers
  • N/A (baseline compound)
  • Daily (topical) or 2–3×/week (injectable)
  • Essential structural remodeling component. One of few peptides with documented transcriptomic effects on tissue repair pathways
  • BPC-157
  • VEGF upregulation, nitric oxide modulation, gut-brain axis signaling
  • Angiogenesis, tendon/ligament repair, gut integrity
  • Complementary. GHK-Cu handles ECM synthesis while BPC-157 drives vascularization
  • Daily during acute phases, 3×/week maintenance
  • Best pairing for tissue repair stacks. Addresses blood supply bottleneck that limits collagen deposition efficacy
  • Epitalon (Epithalon)
  • Telomerase activation, pineal gland function restoration
  • Cellular replication capacity, circadian rhythm optimization
  • Non-overlapping. Epitalon targets DNA-level aging while GHK-Cu addresses extracellular matrix
  • Cyclical (10–20 days on, 4–6 months off)
  • Complementary but operates at different biological level. Combine for cellular + structural approach
  • NAD+ Precursors (NMN/NR)
  • NAD+ restoration for sirtuin activation and mitochondrial function
  • Metabolic efficiency, DNA repair enzyme function
  • Indirect synergy through improved cellular energy status
  • Daily oral supplementation
  • Enhances baseline cellular function but doesn't directly impact GHK-Cu's collagen signaling. Useful foundation
  • Retinoids (Tretinoin)
  • Retinoic acid receptor activation increasing cell turnover
  • Epidermal renewal, reduction of fine lines, hyperpigmentation correction
  • Potentially synergistic but irritation risk when layered. Dermatological protocols often alternate days
  • Nightly (topical)
  • Proven efficacy but mechanism overlap with GHK-Cu on collagen gene expression. May not justify stacking both topically
  • Growth Hormone Secretagogues
  • GH/IGF-1 axis stimulation
  • Muscle preservation, lipolysis, overall anabolic signaling
  • Complementary. GH supports systemic anabolism while GHK-Cu targets dermal structure
  • Daily (MK-677 oral) or 5 days on/2 off (GHRP-2 injectable)
  • Strong pairing for comprehensive body recomposition + skin quality. Non-redundant pathways